Proteomic analysis for developing new biomarkers of hepatocellular carcinoma

doi:10.4254/wjh.v2.i3.127

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 3

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4245)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

439

HTML

3552

Figures (1-4)

124

Tables (1-2)

130

Sum=4245

Mar 27, 2010 (publication date) through Apr 27, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Hepatol. Mar 27, 2010; 2(3): 127-135
Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.127

Full Size Figure Download Figure

Figure 2 Plasma levels of Apo-A1, Apo-A4 and Apo-E in controls and HCC patients. Apo-A4 was significantly higher in patients without HCC than in patients with HCC (2.1 ± 0.4 vs 1.4 ± 0.5; ^bP < 0.01).

Citation: Pleguezuelo M, Lopez-Sanchez LM, Rodriguez-Ariza A, Montero JL, Briceno J, Ciria R, Muntane J, Mata ML. Proteomic analysis for developing new biomarkers of hepatocellular carcinoma. World J Hepatol 2010; 2(3): 127-135
URL: https://www.wjgnet.com/1948-5182/full/v2/i3/127.htm
DOI: https://dx.doi.org/10.4254/wjh.v2.i3.127